Nemaura Medical Inc. (NASDAQ: NMRD) Helping Diabetic Individuals Safeguard Themselves From COVID-19
1 in 8 adults are forecast to suffer from diabetes by 2024, with over 1 in 10 deaths in 2021 a direct result of the diseaseAs many as 40% of Covid-19 related fatalities in the US also suffered from diabetes at the time of their passingNemaura Medical is a medical technology company focused on developing non-invasive wearable diagnostic devicesIn addition to sugarBEAT, its flagship device,…